Canada Markets closed

Hamilton Thorne Ltd. (HTL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.5300-0.0100 (-0.65%)
At close: 02:25PM EST
Full screen
Previous Close1.5400
Open1.5000
Bid1.5200 x 0
Ask1.5500 x 0
Day's Range1.4800 - 1.5500
52 Week Range1.3100 - 2.1400
Volume88,398
Avg. Volume47,593
Market Cap216.582M
Beta (5Y Monthly)0.83
PE Ratio (TTM)170.00
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    Hamilton Thorne Announces Passing of Diarmaid Douglas-Hamilton

    BEVERLY, Mass. and TORONTO, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies ("ART") research, and cell biology markets, today announces the passing of Diarmaid Douglas-Hamilton, Cofounder and Chief Technology Officer of Hamilton Thorne. Diarmaid passed away on January 19 at age 82, at his lab in Beverly, MA, after a he

  • GlobeNewswire

    Hamilton Thorne Announces the Acquisition of Microptic, S.L.

    • Strengthens Hamilton Thorne Footprint in Computer Assisted Semen Analysis (CASA) for the IVF clinic • Significantly expands expertise in artificial intelligence (AI) enabled product offerings • Expands direct sales and support platform for the Hamilton Thorne group’s product portfolio in Europe BEVERLY, Mass. and TORONTO, Dec. 01, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL) ("Hamilton Thorne" or the "Company"), a leading provider of precision instruments, consumables, software a

  • GlobeNewswire

    Hamilton Thorne Reports Financial and Operational Results for the Quarter and Nine Months Ended September 30, 2022

    Revenues up 6% for the quarter and 14% for the nine months despite supply chain issues and significant foreign currency swings Organic growth of 17% for the Quarter BEVERLY, Mass. and TORONTO, Nov. 22, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results for the quarter and nine